batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. ESMO 2023 – Nectin-4 in focus 24 October 2023 ESMO 2023 – BioNTech still has work to do on Claudin6 24 October 2023 ESMO 2023 – more hope for a new Car-T target 23 October 2023 ESMO 2023 – regulators come under fire for Retevmo trial requirements 23 October 2023 ESMO 2023 – Biontech’s Neon buy fails to shine 23 October 2023 ESMO 2023 – Merck makes its KRAS entrance 22 October 2023 ESMO 2023 – Daiichi shows why Merck paid $1.5bn for CDH6 22 October 2023 ESMO 2023 – the colorectal KRAS pipeline swells again 22 October 2023 Load More